The Journal of Immunology, Vol 138, Issue 9 2988-2993, Copyright © 1987 by American Association of Immunologists

ARTICLES

Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation

L Weiss, JF Delfraissy, A Vazquez, C Wallon, P Galanaud and MD Kazatchkine

The addition of monoclonal antibodies against the human C3b/C4b receptor (CR1) to cultures of peripheral blood lymphocytes in the presence of suboptimal amounts of TNP bound to polyacrylamide beads enhanced by 150 to 400% the specific anti-TNP response, as measured by a plaque-forming cell assay on day 7. Anti-CR1 antibodies similarly enhanced the anti-fluorescein antibody response. Enhancement only occurred in cultures performed in the presence of the relevant antigen. No enhancing effect on the anti-TNP response was observed on addition to cultures of monoclonal antibodies directed against other surface antigens of B cells or an anti-T cell antibody of the same subclass as that of anti-CR1 antibodies. Anti-CR1 antibodies alone did not induce nonspecific B cell proliferation and did not provide B cells with a first signal for proliferation in the presence of a source of B cell growth factors. Anti-CR1 antibodies did not enhance the nonspecific proliferative response of B cells to growth factors derived from PHA- stimulated T cells, semi-purified BCGF 20 KD, BCGF 50 KD, or recombinant IL 2 in the presence of anti-mu. In this respect, the effect of anti-CR1 antibodies differs from that of anti-CR2 antibodies which interact with early stages of B cell activation. In contrast, anti-CR1 antibodies enhanced specific differentiation of antigen- activated B cells in the absence of T cells when soluble T cell factors were provided. Similar results were obtained by using either of two sources of differentiation factors, the MLA-144 supernatant or a 30 to 15 KD fraction from PHA-stimulated T cells. These results indicate that triggering of CR1 on B cells positively regulates the specific antibody response to low doses of antigen by enhancing B cell differentiation whether T cell help is provided by intact T cells or by T cell-derived differentiation factors.

This article has been cited by other articles:

				R. T.K. Pang, T. C.W. Poon, K.C. A. Chan, N. L.S. Lee, R. W.K. Chiu, Y.-K. Tong, R. M.Y. Wong, S. S.C. Chim, S. M. Ngai, J. J.Y. Sung, et al. Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome Clin. Chem., March 1, 2006; 52(3): 421 - 429. [Abstract] [Full Text] [PDF]

				X. Wu, N. Jiang, C. Deppong, J. Singh, G. Dolecki, D. Mao, L. Morel, and H. D. Molina A Role for the Cr2 Gene in Modifying Autoantibody Production in Systemic Lupus Erythematosus J. Immunol., August 1, 2002; 169(3): 1587 - 1592. [Abstract] [Full Text] [PDF]

				M. Jozsi, J. Prechl, Z. Bajtay, and A. Erdei Complement Receptor Type 1 (CD35) Mediates Inhibitory Signals in Human B Lymphocytes J. Immunol., March 15, 2002; 168(6): 2782 - 2788. [Abstract] [Full Text] [PDF]

				X. Wu, N. Jiang, Y.-F. Fang, C. Xu, D. Mao, J. Singh, Y.-X. Fu, and H. Molina Impaired Affinity Maturation in Cr2-/- Mice Is Rescued by Adjuvants Without Improvement in Germinal Center Development J. Immunol., September 15, 2000; 165(6): 3119 - 3127. [Abstract] [Full Text] [PDF]

				K. J. Marchbank, C. C. Watson, D. F. Ritsema, and V. M. Holers Expression of Human Complement Receptor 2 (CR2, CD21) in Cr2-/- Mice Restores Humoral Immune Function J. Immunol., September 1, 2000; 165(5): 2354 - 2361. [Abstract] [Full Text] [PDF]

				Y. Fang, C. Xu, Y.-X. Fu, V. M. Holers, and H. Molina Expression of Complement Receptors 1 and 2 on Follicular Dendritic Cells Is Necessary for the Generation of a Strong Antigen-Specific IgG Response J. Immunol., June 1, 1998; 160(11): 5273 - 5279. [Abstract] [Full Text] [PDF]